Patent application number | Description | Published |
20080226569 | Polyurethane dispersions for use in personal care products - The invention relates to an aqueous polyurethane dispersion suitable for use in personal care products, the dispersed polyurethane comprising the reaction products of:
| 09-18-2008 |
20090022678 | POLYURETHANE DISPERSIONS FOR USE IN PERSONAL CARE PRODUCTS - The invention relates to an aqueous polyurethane dispersion suitable for use in personal care products, the dispersed polyurethane comprising the reaction products of:
| 01-22-2009 |
20090030146 | Polyurethane dispersions for sealants - An isocyanate-terminated prepolymer having an isocyanate group content of about 2 to 7% by weight is provided. The prepolymer comprises the reaction product of a) at least one polyether diol having a number average molecular weight of 3000 to 5000; b) at least one active-hydrogen containing material having a number average molecular weight of 200 to 700 and containing two or three hydroxyl groups and optionally one carboxy group; c) at least one hydroxyalkane carboxylic acid having a number average molecular weight of less than about 200; d) optionally, a polyether monol having a number average molecular weight between 400-3,000; e) optionally, a polyether triol having a number average molecular weight of 3,000 to 9,000; and f) an aliphatic and/or cycloaliphatic diisocyanate. | 01-29-2009 |
20090041689 | POLYURETHANE DISPERSIONS BASED ON POLYCARBONATE POLYOLS AND SUITABLE FOR USE IN PERSONAL CARE PRODUCTS - The invention relates to a process for preparing an aqueous polyurethane dispersion suitable for use in personal care products, wherein the polyurethane is based on one or more polycarbonate polyols. | 02-12-2009 |
20130101540 | AQUEOUS DISPERSIONS OF POLYURETHANE AND NANOPARTICLES - The present disclosure is directed to aqueous dispersions comprising polyurethane and nanoparticles, and processes for preparing the aqueous dispersions. The dispersions comprise aqueous polyurethane dispersions having nanoparticles covalently incorporated into the polymer matrix. The dispersions are prepared by reacting isocyanate groups present on the polyurethane chain ends with free amine groups on a hydroxy- or amino-functionalized nanoparticle to covalently attach the polyurethane and the nanoparticle through urethane or urea linkages, respectively. | 04-25-2013 |
20140296428 | MODIFIED POLYURETHANES - The present invention relates to isocyanate functional prepolymers, aqueous polyurethane dispersions produced from the prepolymers and various uses of such dispersions. The prepolymers are prepared by reacting a diisocyanate, a dihydroxy compound having a number average molecular weight of from about 700 to about 16,000, and a trihydroxy component of the formula: | 10-02-2014 |
20150080352 | AQUEOUS POLYURETHANE DISPERSION IN THE TREATMENT OF ACNE - The present invention describes a surprising effect of an aqueous polyurethane dispersion on the efficacy of active ingredients in the anti-acne treatment. The aqueous polyurethane dispersion was able to reduce irritation and substantially enhance efficacy of the salicylic acid and/or salicylic acid derivative in the topical anti-acne serum. | 03-19-2015 |
Patent application number | Description | Published |
20120157189 | SYSTEMS AND METHODS FOR PROVIDING AWARDS AND ADVERTISEMENT CONTENT WITHIN A GAMING ENVIRONMENT - Computer-implemented methods for proving awards and advertisement content within a gaming environment are described. In one example embodiment, a method comprises receiving predetermined advertisement content selection criteria for selecting the advertisement content, selecting the advertisement content from an advertisement database based on the predetermined advertisement content selection criteria, and selectively providing the advertisement content for a surface of a virtual object within the game. In another example embodiment, a method comprises receiving a request to provide the award to a player playing a game, receiving predetermined award selection criteria for selecting the award, selecting the award from an award database based on the predetermined award selection criteria, and selectively providing the award to the player. The predetermined selection criteria include personal preferences, social network data, third party data, geographical locations, and demographical data. | 06-21-2012 |
20120157190 | SYSTEMS AND METHODS FOR PROVIDING AWARDS AND ADVERTISEMENT CONTENT WITHIN A GAMING ENVIRONMENT - Computer-implemented methods for proving awards and advertisement content within a gaming environment are described. In one example embodiment, a method comprises receiving predetermined advertisement content selection criteria for selecting the advertisement content, selecting the advertisement content from an advertisement database based on the predetermined advertisement content selection criteria, and selectively providing the advertisement content for a surface of a virtual object within the game. In another example embodiment, a method comprises receiving a request to provide the award to a player playing a game, receiving predetermined award selection criteria for selecting the award, selecting the award from an award database based on the predetermined award selection criteria, and selectively providing the award to the player. The predetermined selection criteria include personal preferences, social network data, third party data, geographical locations, and demographical data. | 06-21-2012 |
20120276986 | GAMING SYSTEM HAVING MULTIPLE GAMING MACHINES WHICH PROVIDE BONUS AWARDS - A gaming system including a central server linked to a plurality of gaming machines, gaming tables, hand held gaming devices and/or community gaming displays. The central server monitors wagers placed on any games played. Based at least in part on the wagers placed, the central server determines when one or more bonus events will occur and which players to provide any bonus awards. | 11-01-2012 |
20120283006 | GAMING SYSTEM HAVING MULTIPLE GAMING MACHINES WHICH PROVIDE BONUS AWARDS - A gaming system including a central server linked to a plurality of gaming machines, gaming tables, hand held gaming devices and/or community gaming displays. The central server monitors wagers placed on any games played. Based at least in part on the wagers placed, the central server determines when one or more bonus events will occur and which players to provide any bonus awards. | 11-08-2012 |
20130035993 | METHODS AND SYSTEMS FOR ONLINE QUOTING - Methods and systems for online quoting are disclosed. The method may include receiving a user request for price quotes for services. Based on the use request, service providers associated with the services may be selected, and the price quotes may be calculated based on predetermined parameters of the service providers. When calculated, the price quotes may be provided to the user. | 02-07-2013 |
Patent application number | Description | Published |
20090291081 | Dual-specific IL-1A/IL-1b antibodies - The invention provides an isolated, dual-specific antibody, or an antigen-binding portion thereof, which is specific for human IL-1α and human IL-1β. The dual specific antibodies of the invention also neutralize both human IL-1α and human IL-1β. The invention also provides domain antibodies (dAbs) specific for human IL-1α and human IL-1β. | 11-26-2009 |
20100266531 | IL-17 BINDING PROTEINS - Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions. | 10-21-2010 |
20110117079 | THERAPEUTIC DLL4 BINDING PROTEINS - Improved DLL4 binding proteins are described, including antibodies, CDR-grafted antibodies, human antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis, and/or other angiogenesis-dependent diseases such as ocular neovascularization, or angiogenesis-independent diseases characterized by aberrant DLL4 expression or activity such as autoimmune disorders including multiple sclerosis. | 05-19-2011 |
20130164256 | IMMUNOBINDERS DIRECTED AGAINST TNF - Isolated binding proteins, e.g., antibodies or antigen binding portions thereof, which bind to tumor necrosis factor-alpha (TNF-α), e.g., human TNF-α, and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies. | 06-27-2013 |
20130171146 | DUAL-SPECIFIC IL-1A/ IL-1B ANTIBODIES - The invention provides an isolated, dual-specific antibody, or an antigen-binding portion thereof, which is specific for human IL-1α and human IL-1β. The dual specific antibodies of the invention also neutralize both human IL-1α and human IL-1β. The invention also provides domain antibodies (dAbs) specific for human IL-1α and human IL-1β. | 07-04-2013 |
20130330347 | COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION - Provided herein are antibodies and methods of using the antibodies to treat and diagnose neurite degenerative diseases and disorders. | 12-12-2013 |
20140017246 | IL-17 BINDING PROTEINS - Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions. | 01-16-2014 |
20140023659 | COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION - Provided herein are antibodies and methods of using the antibodies to treat and diagnose neurite degenerative diseases and disorders. | 01-23-2014 |
20140079705 | BISPECIFIC IMMUNOBINDERS DIRECTED AGAINST TNF AND IL-17 - Engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease are provided. | 03-20-2014 |
20140093521 | THERAPEUTIC DLL4 BINDING PROTEINS - Improved DLL4 binding proteins are described, including antibodies, CDR-grafted antibodies, human antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis, and/or other angiogenesis-dependent diseases such as ocular neovascularization, or angiogenesis-independent diseases characterized by aberrant DLL4 expression or activity such as autoimmune disorders including multiple sclerosis. | 04-03-2014 |
20140170152 | IMMUNOBINDERS DIRECTED AGAINST TNF - Isolated binding proteins, e.g., antibodies or antigen binding portions thereof, which bind to tumor necrosis factor-alpha (TNF-α), e.g., human TNF-α, and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies. | 06-19-2014 |
20140335564 | IL-17 BINDING PROTEINS - Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions. | 11-13-2014 |
20140343267 | IL-17 BINDING PROTEINS - Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions. | 11-20-2014 |
20140348834 | IL-17 BINDING PROTEINS - Proteins that bind IL-17 and/or IL-17F are described along with their use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions. | 11-27-2014 |
20140348856 | IL-17 BINDING PROTEINS - Proteins that bind IL-17 and/or IL-17F are described along with their use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions. | 11-27-2014 |
20140356909 | IL-17 BINDING PROTEINS - Proteins that bind IL-17 and/or IL-17F are described along with their use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions. | 12-04-2014 |
20150118156 | COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION - Provided herein are antibodies and methods of using the antibodies to treat and diagnose neurite degenerative diseases and disorders. | 04-30-2015 |
20160060332 | THERAPEUTIC DLL4 BINDING PROTEINS - Improved DLL4 binding proteins are described, including antibodies, CDR-grafted antibodies, human antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis, and/or other angiogenesis-dependent diseases such as ocular neovascularization, or angiogenesis-independent diseases characterized by aberrant DLL4 expression or activity such as autoimmune disorders including multiple sclerosis. | 03-03-2016 |